Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Randomized Study to Evaluate the Effects of Empagliflozin in Combination With Standard Hypoglycemic Therapy on Early and Long-term Results of Planned Percutaneous Coronary Interventions in Patients With Type 2 Diabetes.

NCT04497792 is registered in ClinicalTrials.gov with Research Institute for Complex Problems of Cardiovascular Diseases, Russia as lead sponsor.

NCT NCT04497792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04497792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Randomized Study to Evaluate the Effects of Empagliflozin in Combination With Standard Hypoglycemic Therapy on Early and Long-term Results of Planned Percutaneous Coronary Interventions in Patients With Type 2 Diabetes.
Lead sponsor
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2016
Completion date
November 30, 2019
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, diabetes mellitus, percutaneous coronary intervention